# PeptideScanner evidence objects: Amycretin

Every published version of the records placed with Amycretin, one section per evidence object. The section anchor is the object's path id; the JSON twin is https://peptidescanner.com/evidence/v1/peptides/amycretin.json. Selected public evidence only; not medical advice.

- Objects: 9
- Manifest: https://peptidescanner.com/evidence/v1/manifest.json

---

<a id="clinicaltrials-gov-nct07668401-amycretin-v1"></a>

## ClinicalTrials.gov record NCT07668401

> PeptideScanner retained ClinicalTrials.gov record NCT07668401 at 2026-11-15T17:43:02.409Z. Its registry update date was 2026-08-24, and PeptideScanner's reviewed identity mapping was amycretin.

- Evidence object: `story:clinicaltrials-gov-nct07668401-amycretin:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-08-24
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07668401-amycretin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/amycretin.json#clinicaltrials-gov-nct07668401-amycretin-v1
- Content SHA-256: `f419cc9d245736c371d237478c3d351ec1e203642bafc30297287ffbb383b47b`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07668401 ([`ctg-observation-nct07668401-2026-08-24-5833a93b62ac`](#source-ctg-observation-nct07668401-2026-08-24-5833a93b62ac))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07668401 at 2026-11-15T17:43:02.409Z. Its registry update date was 2026-08-24, and PeptideScanner's reviewed identity mapping was amycretin. ([`ctg-observation-nct07668401-2026-08-24-5833a93b62ac`](#source-ctg-observation-nct07668401-2026-08-24-5833a93b62ac))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07668401 at 2026-11-15T17:43:02.409Z. Its registry update date was 2026-08-24, and PeptideScanner's reviewed identity mapping was amycretin. ([`ctg-observation-nct07668401-2026-08-24-5833a93b62ac`](#source-ctg-observation-nct07668401-2026-08-24-5833a93b62ac))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07668401-2026-08-24-5833a93b62ac`](#source-ctg-observation-nct07668401-2026-08-24-5833a93b62ac))

### Sources

<a id="source-ctg-observation-nct07668401-2026-08-24-5833a93b62ac"></a>
- **ClinicalTrials.gov record NCT07668401 · retained source version 2026-08-24:5833a93b62ac59e564069a1fd4bf8cd19222029a0b3f7ce99899f59f22b177dc** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07668401) (`ctg-observation-nct07668401-2026-08-24-5833a93b62ac`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07668401." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/amycretin.json#clinicaltrials-gov-nct07668401-amycretin-v1 SHA-256: f419cc9d245736c371d237478c3d351ec1e203642bafc30297287ffbb383b47b.

---

<a id="clinicaltrials-gov-nct07720271-amycretin-v1"></a>

## ClinicalTrials.gov record NCT07720271

> PeptideScanner retained ClinicalTrials.gov record NCT07720271 at 2026-11-15T17:43:02.409Z. Its registry update date was 2026-09-28, and PeptideScanner's reviewed identity mapping was amycretin.

- Evidence object: `story:clinicaltrials-gov-nct07720271-amycretin:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-09-28
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07720271-amycretin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/amycretin.json#clinicaltrials-gov-nct07720271-amycretin-v1
- Content SHA-256: `f79e98da34b2e8608f63caef5d60d1ec62bc9e2f1fe70af3ba77a798e1f7446a`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07720271 ([`ctg-observation-nct07720271-2026-09-28-93ed8b5caeb7`](#source-ctg-observation-nct07720271-2026-09-28-93ed8b5caeb7))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07720271 at 2026-11-15T17:43:02.409Z. Its registry update date was 2026-09-28, and PeptideScanner's reviewed identity mapping was amycretin. ([`ctg-observation-nct07720271-2026-09-28-93ed8b5caeb7`](#source-ctg-observation-nct07720271-2026-09-28-93ed8b5caeb7))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07720271 at 2026-11-15T17:43:02.409Z. Its registry update date was 2026-09-28, and PeptideScanner's reviewed identity mapping was amycretin. ([`ctg-observation-nct07720271-2026-09-28-93ed8b5caeb7`](#source-ctg-observation-nct07720271-2026-09-28-93ed8b5caeb7))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07720271-2026-09-28-93ed8b5caeb7`](#source-ctg-observation-nct07720271-2026-09-28-93ed8b5caeb7))

### Sources

<a id="source-ctg-observation-nct07720271-2026-09-28-93ed8b5caeb7"></a>
- **ClinicalTrials.gov record NCT07720271 · retained source version 2026-09-28:93ed8b5caeb775d7d6fbd3c0d4e0c5ce26698ea8c1ae70efd4b447411785d74d** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07720271) (`ctg-observation-nct07720271-2026-09-28-93ed8b5caeb7`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07720271." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/amycretin.json#clinicaltrials-gov-nct07720271-amycretin-v1 SHA-256: f79e98da34b2e8608f63caef5d60d1ec62bc9e2f1fe70af3ba77a798e1f7446a.

---

<a id="clinicaltrials-gov-nct07797335-amycretin-v1"></a>

## ClinicalTrials.gov record NCT07797335

> PeptideScanner retained ClinicalTrials.gov record NCT07797335 at 2026-11-15T17:43:02.409Z. Its registry update date was 2026-09-01, and PeptideScanner's reviewed identity mapping was amycretin.

- Evidence object: `story:clinicaltrials-gov-nct07797335-amycretin:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-09-01
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07797335-amycretin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/amycretin.json#clinicaltrials-gov-nct07797335-amycretin-v1
- Content SHA-256: `8354ac8848ef0a14efd87117083ce85726bd082b935e89e5a5288abe6f7ebe24`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07797335 ([`ctg-observation-nct07797335-2026-09-01-bc9e4b3246b2`](#source-ctg-observation-nct07797335-2026-09-01-bc9e4b3246b2))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07797335 at 2026-11-15T17:43:02.409Z. Its registry update date was 2026-09-01, and PeptideScanner's reviewed identity mapping was amycretin. ([`ctg-observation-nct07797335-2026-09-01-bc9e4b3246b2`](#source-ctg-observation-nct07797335-2026-09-01-bc9e4b3246b2))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07797335 at 2026-11-15T17:43:02.409Z. Its registry update date was 2026-09-01, and PeptideScanner's reviewed identity mapping was amycretin. ([`ctg-observation-nct07797335-2026-09-01-bc9e4b3246b2`](#source-ctg-observation-nct07797335-2026-09-01-bc9e4b3246b2))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07797335-2026-09-01-bc9e4b3246b2`](#source-ctg-observation-nct07797335-2026-09-01-bc9e4b3246b2))

### Sources

<a id="source-ctg-observation-nct07797335-2026-09-01-bc9e4b3246b2"></a>
- **ClinicalTrials.gov record NCT07797335 · retained source version 2026-09-01:bc9e4b3246b2a07cc90834c13fa40cb6e95033b38aa14b8b29396518aff35b74** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07797335) (`ctg-observation-nct07797335-2026-09-01-bc9e4b3246b2`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07797335." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/amycretin.json#clinicaltrials-gov-nct07797335-amycretin-v1 SHA-256: 8354ac8848ef0a14efd87117083ce85726bd082b935e89e5a5288abe6f7ebe24.

---

<a id="clinicaltrials-gov-nct07861100-amycretin-v1"></a>

## ClinicalTrials.gov record NCT07861100

> PeptideScanner retained ClinicalTrials.gov record NCT07861100 at 2026-11-15T17:43:02.409Z. Its registry update date was 2026-10-06, and PeptideScanner's reviewed identity mapping was amycretin.

- Evidence object: `story:clinicaltrials-gov-nct07861100-amycretin:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-10-06
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07861100-amycretin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/amycretin.json#clinicaltrials-gov-nct07861100-amycretin-v1
- Content SHA-256: `89682155ed27ef0e76b6938c07ee8f1db533cb771c55442a7dc028405248fc91`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07861100 ([`ctg-observation-nct07861100-2026-10-06-c1032ee418d6`](#source-ctg-observation-nct07861100-2026-10-06-c1032ee418d6))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07861100 at 2026-11-15T17:43:02.409Z. Its registry update date was 2026-10-06, and PeptideScanner's reviewed identity mapping was amycretin. ([`ctg-observation-nct07861100-2026-10-06-c1032ee418d6`](#source-ctg-observation-nct07861100-2026-10-06-c1032ee418d6))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07861100 at 2026-11-15T17:43:02.409Z. Its registry update date was 2026-10-06, and PeptideScanner's reviewed identity mapping was amycretin. ([`ctg-observation-nct07861100-2026-10-06-c1032ee418d6`](#source-ctg-observation-nct07861100-2026-10-06-c1032ee418d6))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07861100-2026-10-06-c1032ee418d6`](#source-ctg-observation-nct07861100-2026-10-06-c1032ee418d6))

### Sources

<a id="source-ctg-observation-nct07861100-2026-10-06-c1032ee418d6"></a>
- **ClinicalTrials.gov record NCT07861100 · retained source version 2026-10-06:c1032ee418d61646c75ff354e74a7285b9376c0eaeb82c0622036ec003177db0** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07861100) (`ctg-observation-nct07861100-2026-10-06-c1032ee418d6`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07861100." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/amycretin.json#clinicaltrials-gov-nct07861100-amycretin-v1 SHA-256: 89682155ed27ef0e76b6938c07ee8f1db533cb771c55442a7dc028405248fc91.

---

<a id="clinicaltrials-gov-nct07931495-amycretin-v1"></a>

## ClinicalTrials.gov record NCT07931495

> PeptideScanner retained ClinicalTrials.gov record NCT07931495 at 2026-11-15T17:43:02.409Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was amycretin.

- Evidence object: `story:clinicaltrials-gov-nct07931495-amycretin:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-11-12
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07931495-amycretin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/amycretin.json#clinicaltrials-gov-nct07931495-amycretin-v1
- Content SHA-256: `f580d7cec15db73c0b4bbdf6f9f5338dd6907c595373c9580f54dabf7c1dd0b3`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07931495 ([`ctg-observation-nct07931495-2026-11-12-23a664ffa2bf`](#source-ctg-observation-nct07931495-2026-11-12-23a664ffa2bf))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07931495 at 2026-11-15T17:43:02.409Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was amycretin. ([`ctg-observation-nct07931495-2026-11-12-23a664ffa2bf`](#source-ctg-observation-nct07931495-2026-11-12-23a664ffa2bf))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07931495 at 2026-11-15T17:43:02.409Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was amycretin. ([`ctg-observation-nct07931495-2026-11-12-23a664ffa2bf`](#source-ctg-observation-nct07931495-2026-11-12-23a664ffa2bf))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07931495-2026-11-12-23a664ffa2bf`](#source-ctg-observation-nct07931495-2026-11-12-23a664ffa2bf))

### Sources

<a id="source-ctg-observation-nct07931495-2026-11-12-23a664ffa2bf"></a>
- **ClinicalTrials.gov record NCT07931495 · retained source version 2026-11-12:23a664ffa2bff21e8dd34305b3456a3ee5f65f216d24ab4d40b786451213bde4** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07931495) (`ctg-observation-nct07931495-2026-11-12-23a664ffa2bf`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07931495." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/amycretin.json#clinicaltrials-gov-nct07931495-amycretin-v1 SHA-256: f580d7cec15db73c0b4bbdf6f9f5338dd6907c595373c9580f54dabf7c1dd0b3.

---

<a id="clinicaltrials-gov-nct07931547-amycretin-v1"></a>

## ClinicalTrials.gov record NCT07931547

> PeptideScanner retained ClinicalTrials.gov record NCT07931547 at 2026-11-15T17:43:02.409Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was amycretin.

- Evidence object: `story:clinicaltrials-gov-nct07931547-amycretin:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-11-12
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07931547-amycretin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/amycretin.json#clinicaltrials-gov-nct07931547-amycretin-v1
- Content SHA-256: `6f962ac4c120b8cac9b0867cc8b041362a62b36266f2571e104866ff114647d7`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07931547 ([`ctg-observation-nct07931547-2026-11-12-2d2f13db63aa`](#source-ctg-observation-nct07931547-2026-11-12-2d2f13db63aa))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07931547 at 2026-11-15T17:43:02.409Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was amycretin. ([`ctg-observation-nct07931547-2026-11-12-2d2f13db63aa`](#source-ctg-observation-nct07931547-2026-11-12-2d2f13db63aa))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07931547 at 2026-11-15T17:43:02.409Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was amycretin. ([`ctg-observation-nct07931547-2026-11-12-2d2f13db63aa`](#source-ctg-observation-nct07931547-2026-11-12-2d2f13db63aa))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07931547-2026-11-12-2d2f13db63aa`](#source-ctg-observation-nct07931547-2026-11-12-2d2f13db63aa))

### Sources

<a id="source-ctg-observation-nct07931547-2026-11-12-2d2f13db63aa"></a>
- **ClinicalTrials.gov record NCT07931547 · retained source version 2026-11-12:2d2f13db63aaf8b3fc36fdb710419bcd545343ee84a805e746017fc30430e350** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07931547) (`ctg-observation-nct07931547-2026-11-12-2d2f13db63aa`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07931547." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/amycretin.json#clinicaltrials-gov-nct07931547-amycretin-v1 SHA-256: 6f962ac4c120b8cac9b0867cc8b041362a62b36266f2571e104866ff114647d7.

---

<a id="pubmed-pmid-40550229-amycretin-v1"></a>

## PubMed record PMID 40550229

> PeptideScanner retained PubMed bibliographic metadata for PMID 40550229 at 2026-07-30T18:25:48.707Z. PubMed recorded a metadata revision date of 2025-07-14 and an Entrez history date of 2025-06-23. PeptideScanner associated this retained record with the identity slug amycretin. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-40550229-amycretin:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-07-14
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-40550229-amycretin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/amycretin.json#pubmed-pmid-40550229-amycretin-v1
- Content SHA-256: `9da134b422eb3e9d936198d171cf8feab6b733a02faed07b41a7af8628452e57`

### Claims and source pins

#### Headline

PubMed record PMID 40550229 ([`pubmed-observation-pmid-40550229-2025-07-14-421e98d01953`](#source-pubmed-observation-pmid-40550229-2025-07-14-421e98d01953))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 40550229 at 2026-07-30T18:25:48.707Z. PubMed recorded a metadata revision date of 2025-07-14 and an Entrez history date of 2025-06-23. PeptideScanner associated this retained record with the identity slug amycretin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-40550229-2025-07-14-421e98d01953`](#source-pubmed-observation-pmid-40550229-2025-07-14-421e98d01953))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 40550229 at 2026-07-30T18:25:48.707Z. PubMed recorded a metadata revision date of 2025-07-14 and an Entrez history date of 2025-06-23. PeptideScanner associated this retained record with the identity slug amycretin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-40550229-2025-07-14-421e98d01953`](#source-pubmed-observation-pmid-40550229-2025-07-14-421e98d01953))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-40550229-2025-07-14-421e98d01953`](#source-pubmed-observation-pmid-40550229-2025-07-14-421e98d01953))

### Sources

<a id="source-pubmed-observation-pmid-40550229-2025-07-14-421e98d01953"></a>
- **PubMed record PMID 40550229 · retained source version 1:2025-07-14:current:421e98d01953dc33ccfb0903cd3e37a8617ee738fc71df55017e50e3d495cb5a** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/40550229/) (`pubmed-observation-pmid-40550229-2025-07-14-421e98d01953`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 40550229." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/amycretin.json#pubmed-pmid-40550229-amycretin-v1 SHA-256: 9da134b422eb3e9d936198d171cf8feab6b733a02faed07b41a7af8628452e57.

---

<a id="pubmed-pmid-40550231-amycretin-v1"></a>

## PubMed record PMID 40550231

> PeptideScanner retained PubMed bibliographic metadata for PMID 40550231 at 2026-07-30T18:25:48.707Z. PubMed recorded a metadata revision date of 2025-07-14 and an Entrez history date of 2025-06-23. PeptideScanner associated this retained record with the identity slug amycretin. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-40550231-amycretin:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-07-14
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-40550231-amycretin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/amycretin.json#pubmed-pmid-40550231-amycretin-v1
- Content SHA-256: `8d2a989fc2db523b774464b4112f30b38e34da6c124ba4e0566b4cc868459a16`

### Claims and source pins

#### Headline

PubMed record PMID 40550231 ([`pubmed-observation-pmid-40550231-2025-07-14-35c6845a6d91`](#source-pubmed-observation-pmid-40550231-2025-07-14-35c6845a6d91))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 40550231 at 2026-07-30T18:25:48.707Z. PubMed recorded a metadata revision date of 2025-07-14 and an Entrez history date of 2025-06-23. PeptideScanner associated this retained record with the identity slug amycretin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-40550231-2025-07-14-35c6845a6d91`](#source-pubmed-observation-pmid-40550231-2025-07-14-35c6845a6d91))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 40550231 at 2026-07-30T18:25:48.707Z. PubMed recorded a metadata revision date of 2025-07-14 and an Entrez history date of 2025-06-23. PeptideScanner associated this retained record with the identity slug amycretin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-40550231-2025-07-14-35c6845a6d91`](#source-pubmed-observation-pmid-40550231-2025-07-14-35c6845a6d91))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-40550231-2025-07-14-35c6845a6d91`](#source-pubmed-observation-pmid-40550231-2025-07-14-35c6845a6d91))

### Sources

<a id="source-pubmed-observation-pmid-40550231-2025-07-14-35c6845a6d91"></a>
- **PubMed record PMID 40550231 · retained source version 1:2025-07-14:current:35c6845a6d918467d961e5467ebb0130016b75a21633c8be586523998c4571bd** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/40550231/) (`pubmed-observation-pmid-40550231-2025-07-14-35c6845a6d91`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 40550231." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/amycretin.json#pubmed-pmid-40550231-amycretin-v1 SHA-256: 8d2a989fc2db523b774464b4112f30b38e34da6c124ba4e0566b4cc868459a16.

---

<a id="pubmed-pmid-40550232-amycretin-v1"></a>

## PubMed record PMID 40550232

> PeptideScanner retained PubMed bibliographic metadata for PMID 40550232 at 2026-07-30T18:22:52.359Z. PubMed recorded a metadata revision date of 2025-09-11 and an Entrez history date of 2025-06-23. PeptideScanner associated this retained record with the identity slug amycretin. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-40550232-amycretin:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-09-11
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-40550232-amycretin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/amycretin.json#pubmed-pmid-40550232-amycretin-v1
- Content SHA-256: `586b3ae8f7ec23ee6a9c3de15747d81000995a146d3126baf7744a2a4f6bacde`

### Claims and source pins

#### Headline

PubMed record PMID 40550232 ([`pubmed-observation-pmid-40550232-2025-09-11-3d4c09f08472`](#source-pubmed-observation-pmid-40550232-2025-09-11-3d4c09f08472))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 40550232 at 2026-07-30T18:22:52.359Z. PubMed recorded a metadata revision date of 2025-09-11 and an Entrez history date of 2025-06-23. PeptideScanner associated this retained record with the identity slug amycretin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-40550232-2025-09-11-3d4c09f08472`](#source-pubmed-observation-pmid-40550232-2025-09-11-3d4c09f08472))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 40550232 at 2026-07-30T18:22:52.359Z. PubMed recorded a metadata revision date of 2025-09-11 and an Entrez history date of 2025-06-23. PeptideScanner associated this retained record with the identity slug amycretin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-40550232-2025-09-11-3d4c09f08472`](#source-pubmed-observation-pmid-40550232-2025-09-11-3d4c09f08472))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-40550232-2025-09-11-3d4c09f08472`](#source-pubmed-observation-pmid-40550232-2025-09-11-3d4c09f08472))

### Sources

<a id="source-pubmed-observation-pmid-40550232-2025-09-11-3d4c09f08472"></a>
- **PubMed record PMID 40550232 · retained source version 1:2025-09-11:current:3d4c09f084724be9ab617657c971775a1a7f0e18389309cefa0bae51a5d403a0** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/40550232/) (`pubmed-observation-pmid-40550232-2025-09-11-3d4c09f08472`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 40550232." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/amycretin.json#pubmed-pmid-40550232-amycretin-v1 SHA-256: 586b3ae8f7ec23ee6a9c3de15747d81000995a146d3126baf7744a2a4f6bacde.

